全文获取类型
收费全文 | 3587篇 |
免费 | 173篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 71篇 |
妇产科学 | 57篇 |
基础医学 | 355篇 |
口腔科学 | 53篇 |
临床医学 | 273篇 |
内科学 | 1157篇 |
皮肤病学 | 74篇 |
神经病学 | 296篇 |
特种医学 | 159篇 |
外科学 | 586篇 |
综合类 | 16篇 |
一般理论 | 1篇 |
预防医学 | 200篇 |
眼科学 | 22篇 |
药学 | 152篇 |
中国医学 | 2篇 |
肿瘤学 | 308篇 |
出版年
2024年 | 6篇 |
2023年 | 54篇 |
2022年 | 104篇 |
2021年 | 191篇 |
2020年 | 105篇 |
2019年 | 130篇 |
2018年 | 163篇 |
2017年 | 108篇 |
2016年 | 130篇 |
2015年 | 129篇 |
2014年 | 153篇 |
2013年 | 220篇 |
2012年 | 283篇 |
2011年 | 305篇 |
2010年 | 160篇 |
2009年 | 138篇 |
2008年 | 229篇 |
2007年 | 216篇 |
2006年 | 179篇 |
2005年 | 186篇 |
2004年 | 128篇 |
2003年 | 105篇 |
2002年 | 106篇 |
2001年 | 20篇 |
2000年 | 16篇 |
1999年 | 22篇 |
1998年 | 29篇 |
1997年 | 18篇 |
1996年 | 16篇 |
1995年 | 16篇 |
1994年 | 13篇 |
1993年 | 12篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 10篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 9篇 |
1986年 | 11篇 |
1985年 | 6篇 |
1984年 | 17篇 |
1983年 | 3篇 |
1981年 | 5篇 |
1980年 | 4篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1972年 | 2篇 |
1969年 | 3篇 |
1933年 | 2篇 |
1907年 | 2篇 |
排序方式: 共有3810条查询结果,搜索用时 0 毫秒
91.
92.
Mario Bonomini Lorenzo Di Liberato Goffredo Del Rosso Antonio Stingone Giancarlo Marinangeli Agostino Consoli Silvio Bertoli Amedeo De Vecchi Emanuele Bosi Roberto Russo Roberto Corciulo Loreto Gesualdo Francesco Giorgino Paolo Cerasoli Augusto Di Castelnuovo Maria Pia Monaco Ty Shockley Claudia Rossi Arduino Arduini 《American journal of kidney diseases》2013
93.
94.
95.
Di Nardo G Aloi M Oliva S Civitelli F Casciani E Cucchiara S 《Inflammatory bowel diseases》2012,18(9):1760-1776
Investigation of the small bowel has been traditionally a challenge for pediatric gastroenterologists due to its location, anatomical tortuosity, and invasiveness of the available techniques. Recently, there has been a remarkable improvement in imaging and endoscopic tools aimed at exploring successfully the small intestine in inflammatory bowel disease. The former are represented by ultrasonography (either alone or with administration of oral contrast agents) and by magnetic resonance: both have provided accurate methods to detect structural bowel changes, diminishing patient discomfort and precluding radiation hazard. The use of traditional radiologic techniques such as fluoroscopy have been markedly reduced due to radiation exposure and inability to depict transmural inflammation or extraluminal complications. Among the novel endoscopic tools, capsule endoscopy and balloon-assisted enteroscopy have tremendously opened new diagnostic and therapeutic perspectives, by allowing the direct visualization of small intestinal mucosa and, through enteroscopy, histological diagnosis as well as therapeutic interventions such as stricture dilation and bleeding treatment. These endoscopic techniques should always be preceded by imaging of the intestine in order to identify strictures. This review describes the most recent progress with the employment of novel imaging and endoscopic methodologies for investigating the small bowel in children with suspected or established Crohn's disease. 相似文献
96.
97.
98.
99.
Antonio B. Porcaro Alessandro Borsato Mario Romano Teodoro Sava Claudio Ghimenton Filippo Migliorini Carmelo Monaco Emanuele Rubilotta Stefano Zecchini Antoniolli Vincenzo Lacola Stefania Montemezzi 《World journal of urology》2013,31(5):1245-1251
Objectives
To assess the accuracy of intra-rectal coil magnetic resonance imaging (ER-MRI) for staging early prostate cancer (EPC).Materials and methods
ER-MRI was performed with the Magnetom Symphony 1.5 Tesla system. ER-MRI and pathology findings were statistically correlated.Results
One hundred and fifty-four consecutive patients underwent radical prostatectomy (RRP) for EPC (cT1c-2 Nx M0). An average age was 66, mean PSA 11.04 µg/L (median 7.33 µg/L) and mean pathologic Gleason score 6. Pathology detected 97 out of 154 patients (63 %) as EPC and 57 cases (37 %) as extra-prostate extension (EPED) (pT3) with extra-capsular extension (ECE) (pT3a) in 41 (27 %) and seminal vesicle invasion (SVI) (pT3b) in 16 (10 %). ER-MRI staged 100 patients (65 %) as cT2 and 54 (35 %) as EPED with ECE in 37 cases (24 %) and SVI in 17 (11 %). ER-MRI sensitivity, specificity, positive predictive value, negative predictive value, overall accuracy resulted respectively 0.78, 0.96, 0.86, 0.92, 0.91 for ECE as well as 0.88, 0.98, 0.82, 0.99 and 0.97 for SVI.Conclusion
ER-MRI was effective in detecting preoperative EPC under-staging. In the next future, multi-parametric 3-Tesla ER-MRI will be the procedure for diagnosing, staging and following-up prostate cancer patients. 相似文献100.
Emanuele Durante‐Mangoni Domenico Iossa Daniela Pinto Rosa Molaro Federica Agrusta Cristiano Amarelli Enrico Ragone Maria Grimaldi Ciro Maiello Riccardo Utili 《Clinical transplantation》2013,27(3):E282-E288
Chronic hepatitis B is prevalent in the transplant setting and may cause significant complications. Effective control of viral replication is needed. Besides lamivudine, very little data are available on safety and efficacy of other drugs. We describe our experience with adefovir dipivoxil (ADV) in eight heart transplant recipients. Studies included a baseline liver biopsy, thrice‐monthly clinical, biochemical, and virological evaluations, including genotyping and viral load, polymerase gene sequencing for resistance mutations, liver and kidney function tests, and liver ultrasound. Of eight patients, six had fibrosis score ≤2 and negative HBeAg and seven had hepatitis B virus (HBV) genotype D. Upon ADV start, median HBV‐DNA was 5.8 logs IU/mL and alanine aminotransferase (ALT) levels were mostly normal. All patients had prior mild‐to‐moderate renal functional impairment. Seven of eight patients started ADV after a previous course of lamivudine. Five of these seven patients became HBV‐DNA undetectable within eight months. One patient with low baseline viremia started ADV de novo and suppressed HBV‐DNA. Median treatment duration was 66 months. ADV daily dose was halved in one patient due to renal function worsening. No ALT flares, hypophosphatemia, liver decompensation, liver cancer, or emergence of resistance was observed. Our data suggest that ADV may be a safe and effective rescue treatment for heart transplant recipients with lamivudine‐resistant chronic hepatitis B. 相似文献